Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thomson Reuters (TRI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Thomson Reuters (TRI) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • Thomson Reuters' Cash & Equivalents changed 0.0% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.0 billion for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Thomson Reuters' Cash & Equivalents stood at $2.0 billion, which was down 0.0% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Thomson Reuters' Cash & Equivalents ranged from a high of $2.5 billion in Q3 2023 and a low of $654.0 million during Q1 2022
  • Moreover, its 5-year median value for Cash & Equivalents was $1.7 billion (2023), whereas its average is $1.5 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 6678.05% in 2022, then soared by 22339.33% in 2023.
  • Thomson Reuters' Cash & Equivalents (Quarter) stood at $778.0 million in 2021, then skyrocketed by 37.4% to $1.1 billion in 2022, then grew by 21.42% to $1.3 billion in 2023, then skyrocketed by 51.62% to $2.0 billion in 2024, then changed by 0.0% to $2.0 billion in 2025.
  • Its Cash & Equivalents stands at $2.0 billion for Q4 2025, versus $2.0 billion for Q3 2025 and $664.0 million for Q2 2025.